Viagra developer Furchgott dead at 92: report

May 24, 2009
US pharmacologist Robert Furchgott, a Nobel prize-winning pharmacologist whose work with the gas nitric oxide helped develop the anti-impotency drug Viagra, has died at the age of 92, The New York Times has reported. Furchgott, seen here in 1998, was from South Carolina.

Robert Furchgott, a Nobel prize-winning pharmacologist whose work with the gas nitric oxide helped develop the anti-impotency drug Viagra, has died at the age of 92, The New York Times reported Sunday.

The newspaper said his daughter Susan Furchgott had confirmed the death, which occurred on Tuesday in Seattle.

According to The Times, research by Furchgott, Louis Ignarro and Ferid Murad has proven that , widely known as an air pollutant, also acted as an important signal in the , mediating pressure and blood flow.

This ability of nitric oxide to enlarge blood vessels was an important step in the development by Pfizer Corporation of the drug sildenafil citrate, which is also known as .

The drug ameliorates impotence by increasing blood flow to the penis. Pfizer has called the nitric acid discovery "a small piece of information" in its inventing of the drug.

In awarding Furchgott and his colleagues the prize for medicine in 1998, the Swedish Nobel assembly praised them for providing the first proof that a gas can perform important biochemical functions in the body.

Furchgott was born in Charleston, South Carolina, on June 4, 1916, and developed an early interest in birds, shells and other natural phenomena. He earned a degree in chemistry from the University of North Carolina and a doctorate in biochemistry from Northwestern University.

In the 1950s, Furchgott developed a method for determining how blood vessels respond to medications, neurotransmitters and hormones, using a rabbit?s artery. This allowed him to study the effects of drugs on vascular smooth muscle.

(c) 2009 AFP

Explore further: Flu vaccine may hold key to preventing heart disease

add to favorites email to friend print save as pdf

Related Stories

Reducing side-effects of painkillers

Sep 12, 2006

Cardiff University researchers have increased the understanding of why some painkillers increase the risk of heart attack and stroke.

NanoViagra

Apr 28, 2009

(PhysOrg.com) -- A new generation of anti-impotency drugs based on nanoparticles might be coming quickly. Researchers at the Albert Einstein College of Medicine in New York presenting at the 104'th Annual Meeting ...

Recommended for you

Supercomputers link proteins to drug side effects

Oct 20, 2014

New medications created by pharmaceutical companies have helped millions of Americans alleviate pain and suffering from their medical conditions. However, the drug creation process often misses many side ...

No added benefit proven for umeclidinium/vilanterol in COPD

Oct 20, 2014

The drug combination umeclidinium/vilanterol (trade name Anoro) has been approved since May 2014 for adults with chronic obstructive pulmonary disease (COPD). In an early benefit assessment pursuant to the Act on the Reform ...

User comments : 2

Adjust slider to filter visible comments by rank

Display comments: newest first

Fakeer
5 / 5 (2) May 25, 2009
RIP Robert Furchgott as billions of erections salute your contribution to science.
Soylent
not rated yet May 25, 2009
Rigor mortis, the ultimate in stiffness.

RIP Robert Furchgott.